Clinical Report: Top 10 evidence-based essentials in pulmonology

Background

Pulmonary medicine is critical for managing a variety of respiratory conditions, necessitating adherence to clinical guidelines and evidence-based practices. The integration of recent research findings into clinical protocols is essential for managing diseases like asthma and COPD.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

• The 2026 GINA Strategy Report updates asthma management guidelines based on recent literature.
• The 2026 GOLD Report revises COPD management strategies, including treatment algorithms and vaccination recommendations.
• Conditional recommendations for idiopathic pulmonary fibrosis include transbronchial lung cryobiopsy in experienced centers.
• The BOREAS trial demonstrated that dupilumab reduces exacerbations in COPD patients with high eosinophil counts.
• The BATURA trial showed that albuterol-budesonide reduces severe exacerbations compared to albuterol alone in uncontrolled asthma.
• Updated ARDS guidelines recommend corticosteroids and ECMO for selected patients, while advising against prolonged lung recruitment maneuvers.

Clinical Implications

Healthcare professionals should stay informed about the latest guidelines and trial results to ensure evidence-based management of respiratory conditions.

Conclusion

The integration of updated guidelines and trial findings is essential for managing respiratory diseases.

Related Resources & Content

1. Global Initiative for Asthma (GINA), GINA, 2026 -- GINA Strategy Report
2. Global Initiative for Chronic Obstructive Lung Disease (GOLD), GOLD, 2026 -- GOLD Report
3. American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Asociación Latinoamericana de Tórax, ATS/ERS/JRS/ALAT, 2022 -- Idiopathic Pulmonary Fibrosis Guideline
4. European Society of Cardiology/European Respiratory Society, ESC/ERS, 2022 -- Pulmonary Hypertension Guideline
5. American Thoracic Society, ATS, 2023 -- Acute Respiratory Distress Syndrome Management Update
6. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts, NEJM, 2023
7. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma, NEJM, 2017
8. mdspire news — Top 10 evidence-based essentials in pediatrics
9. MDSpire News — Top 10 Evidence-Based Essentials in Internal Medicine
10. mdspire news — Top 10 evidence-based essentials in radiology
11. MDSpire News — Top 10 Evidence-Based Essentials in Otolaryngology
12. Top 10 evidence-based essentials in pediatrics
13. Top 10 Evidence-Based Essentials in Internal Medicine
14. Top 10 evidence-based essentials in radiology
15. Reports - Global Initiative for Asthma - GINA
16. 2026 GOLD Report and Pocket Guide - Global Initiative for Chronic Obstructive Lung Disease - GOLD
17. Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS/ATS statement - PubMed
18. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine | Oxford Academic
19. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension | European Heart Journal | Oxford Academic
20. European Respiratory Society clinical practice guidelines update for the treatment of pulmonary arterial hypertension.
21. An Update on Management of Adult Patients with Acute Respiratory Distress Syndrome: An Official American Thoracic Society Clinical Practice Guideline - PMC
22. Guidelines for the Administration of Neuromuscular Blockade in Adults With ARDS | SCCM
23. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma | New England Journal of Medicine
24. Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD | New England Journal of Medicine
25. Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts | New England Journal of Medicine
26. Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis | New England Journal of Medicine
27. Prone Positioning in Severe Acute Respiratory Distress Syndrome | New England Journal of Medicine